Fixed-combination treatments for intraocular hypertension in Chinese patients – focus on bimatoprost-timolol

References

• ChoHKKeeCPopulation-based glaucoma prevalence studies in AsiansSurv Ophthalmol201459443444724837853
   PubMed Web of Science ®Google Scholar
• YuanZLGlaucoma clinical trials in ChinaZhonghua Yan Ke Za Zhi2012486485487 Chinese22943800
   PubMedGoogle Scholar
• LiHZhangYYLiuSCPrevalence of open-angle glaucoma in southwestern China: the Yongchuan Glaucoma studyJ Huazhong Univ Sci Technolog Med Sci201434113714124496693
   PubMedGoogle Scholar
• HeJZouHTongXPrevalence of primary glaucoma among adults aged 50 years or above population in Huamu community: a cross-sectional survey in Shanghai, 2011Zhonghua Yan Ke Za Zhi2014505349354 Chinese25052804
   PubMedGoogle Scholar
• LiangYBFriedmanDSZhouQHandan Eye Study GroupPrevalence of primary open angle glaucoma in a rural adult Chinese population: the Handan eye studyInvest Ophthalmol Vis Sci201152118250825721896871
   PubMed Web of Science ®Google Scholar
• ZhongHLiJLiCThe prevalence of glaucoma in adult rural Chinese populations of the Bai nationality in Dali: the Yunnan Minority Eye StudyInvest Ophthalmol Vis Sci20125363221322522511635
   PubMed Web of Science ®Google Scholar
• SongWShanLChengFPrevalence of glaucoma in a rural northern China adult population: a population-based survey in Kailu county, inner MongoliaOphthalmology2011118101982198821684607
   PubMed Web of Science ®Google Scholar
• YangYFYuMBProgress of anti-glaucoma fixed combination formulationZhonghua Yan Ke Za Zhi2011472176180 Chinese21426848
   PubMedGoogle Scholar
• European Glaucoma SocietyTerminology and Guidelines for Glaucoma3rd edSavonaEditrice Dogma2008
   Google Scholar
• LichterPRMuschDCGillespieBWCIGTS Study GroupInterim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgeryOphthalmology2001108111943195311713061
   PubMed Web of Science ®Google Scholar
• HeijlALeskeMCBengtssonBHymanLBengtssonBHusseinMEarly Manifest Glaucoma Trial GroupReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol2002120101268127912365904
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressuresAm J Ophthalmol199812644874979780093
   PubMed Web of Science ®Google Scholar
• VanVeldhuisenPCEdererFGaasterlandDEThe AGIS InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol2000130442944011024415
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol20021206701713 discussion 829–83012049574
   PubMed Web of Science ®Google Scholar
• LingZZhangMHuYSafety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertensionChin Med J (Engl)2014127590591024571886
   PubMed Web of Science ®Google Scholar
• XuLChenJHLiJJThe prevalence and its screening methods of primary open angle glaucoma in defined population-based study of rural and urban in BeijingZhonghua Yan Ke Za Zhi20044011726732 Chinese15634477
   PubMedGoogle Scholar
• Chinese Glaucoma Society [Glaucoma treatment guidelines]Zhonghua Yan Ke Za Zhi2014505382383 Chinese
   Google Scholar
• FiscellaRGGreenAPatuszynskiDHWilenskyJMedical therapy cost considerations for glaucomaAm J Ophthalmol20031361182512834665
   PubMed Web of Science ®Google Scholar
• GaoYWuLLiADaily cost of glaucoma medications in ChinaJ Glaucoma200716759459718091176
   PubMed Web of Science ®Google Scholar
• LiangYWoodwardDFGuzmanVMIdentification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesBr J Pharmacol200815451079109318587449
   PubMed Web of Science ®Google Scholar
• TorisCBGabeltBTKaufmanPLUpdate on the mechanism of action of topical prostaglandins for intraocular pressure reductionSurv Ophthalmol200853Suppl 1S107S12019038618
   PubMed Web of Science ®Google Scholar
• ChenJHuangHZhangSChenXSunXExpansion of Schlemm’s canal by travoprost in healthy subjects determined by Fourier-domain optical coherence tomographyInvest Ophthalmol Vis Sci20135421127113423322574
   PubMed Web of Science ®Google Scholar
• WatsonPGBarnettMFParkerVHaybittleJA 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucomaBr J Ophthalmol200185896296811466256
   PubMed Web of Science ®Google Scholar
• ChraiSSMakoidMCEriksenSPRobinsonJRDrop size and initial dosing frequency problems of topically applied ophthalmic drugsJ Pharm Sci19746333333384820359
   PubMed Web of Science ®Google Scholar
• AptelFDenisPBalancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucomaCurr Med Res Opin201127101949195821878000
   PubMed Web of Science ®Google Scholar
• KhouriASRealiniTFechtnerRDUse of fixed-dose combination drugs for the treatment of glaucomaDrugs Aging200724121007101618020533
   PubMed Web of Science ®Google Scholar
• HolmstromSBuchholzPWaltJWickstrømJAagrenMAnalytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucomaCurr Med Res Opin200521111875188316307709
   PubMed Web of Science ®Google Scholar
• WangKXuLYuanZIntraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in ChinaBMC Ophthalmol2014142124568617
   PubMed Web of Science ®Google Scholar
• JinXHQianSHSunXH0.03% bimatoprost ophthalmic solution with 0.005% latanoprost eye drops IOP lowering efficacy and safety comparisonChinese Journal of Practical Ophthalmology2005237712714 Chinese
   Google Scholar
• KongXMSunXHMengFRA comparison of the ocular hypotensive efficacy of three prostaglandin analogsChinese J Opt and Ophthalmology200684228230 Chinese
   Google Scholar
• HuangHLSunXHXiaoMComparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucomaZhonghua Yan Ke Za Zhi2011472109113 Chinese21426839
   PubMedGoogle Scholar
• QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
   PubMed Web of Science ®Google Scholar
• LequeuITheuwisKAbegāo PintoLVandewalleEStalmansILong term IOP lowering efficacy of bimatoprost/timolol fixed combination: a 12 month prospective studyBull Soc Belge Ophtalmol201332210511024923090
   PubMedGoogle Scholar
• KatsanosADastiridouAIFanariotisMKotoulaMTsironiEEBimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertensionJ Ocul Pharmacol Ther2011271677121214361
   PubMed Web of Science ®Google Scholar
• BrandtJDCantorLBKatzLJBatoosinghALChouCBossowska I; Ganfort Investigators GroupIIBimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma200817321121618414107
   PubMed Web of Science ®Google Scholar
• Gutierrez-DiazESilva CottaJMuñoz-NegreteFJGutierrez-OrtizCMorgan-WarrenRJMaltmanJBimatoprost/timolol fixed combination versus latanoprost in treatment-naïve glaucoma patients at high risk of progression: a pilot studyClin Ophthalmol2014872573224748767
   PubMedGoogle Scholar
• CentofantiMOddoneFVetrugnoMEfficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, ran-domized, investigator-masked, clinical studyEur J Ophthalmol2009191667119123151
   PubMed Web of Science ®Google Scholar
• MartinezASanchezMA comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucomaCurr Med Res Opin20072351025103217519068
   PubMed Web of Science ®Google Scholar
• MartinezASanchezMBimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patientsEye (Lond)200923481081818535605
   PubMed Web of Science ®Google Scholar
• MackyTABimatoprost/timolol versus travoprost/timolol fixed combinations in an Egyptian population: a hospital-based prospective randomized studyJ Glaucoma201423856156623429621
   PubMed Web of Science ®Google Scholar
• CentofantiMOddoneFGandolfiSComparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combinationAm J Ophthalmol2010150457558020688314
   PubMed Web of Science ®Google Scholar
• RigolletJPOndateguiJAPastoALopLRandomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleateClin Ophthalmol2011518719121383947
   PubMedGoogle Scholar
• AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trialsEur J Ophthalmol201222151822167538
   PubMed Web of Science ®Google Scholar
• ChengJWChengSWGaoLDLuGCWeiRLIntraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysisPLoS One201279e4507923028770
   PubMed Web of Science ®Google Scholar
• HollóGThe side effects of the prostaglandin analoguesExpert Opin Drug Saf200761455217181451
   PubMed Web of Science ®Google Scholar
• HonrubiaFGarcía-SánchezJPoloVde la CasaJMSotoJConjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trialsBr J Ophthalmol200993331632119019922
   PubMed Web of Science ®Google Scholar
• AptelFCucheratMDenisPEfficacy and tolerability of prostaglan-din analogs: a meta-analysis of randomized controlled clinical trialsJ Glaucoma200817866767319092464
   PubMed Web of Science ®Google Scholar
• InoueKShiokawaMHigaRAdverse periocular reactions to five types of prostaglandin analogsEye (Lond)201226111465147223037910
   PubMed Web of Science ®Google Scholar
• PeplinskiLSAlbiani SmithKDeepening of lid sulcus from topical bimatoprost therapyOptom Vis Sci200481857457715300114
   PubMed Web of Science ®Google Scholar
• ParkJChoHKMoonJIChanges to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprostJpn J Ophthalmol2011551222721331688
   PubMed Web of Science ®Google Scholar
• InoueKShiokawaMWakakuraMTomitaGDeepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogsJ Glaucoma201322862663122936280
   PubMed Web of Science ®Google Scholar
• HollóGTopouzisFFechtnerRDFixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practiceExpert Opin Pharmacother201415121737174724998246
   PubMed Web of Science ®Google Scholar
• MartinezASanchezMEfficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertensionExpert Opin Pharmacother20089113714318076345
   PubMed Web of Science ®Google Scholar
• Management and Therapy Subcommittee of the International Dry Eye WorkShopManagement and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075216317817508120
   PubMed Web of Science ®Google Scholar
• PisellaPJPouliquenPBaudouinCPrevalence of ocular symptoms and signs with preserved and preservative free glaucoma medicationBr J Ophthalmol200286441842311914211
   PubMed Web of Science ®Google Scholar